Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Copy number aberrations in benign serous ovarian tumors: a case for reclassification?
Sally M Hunter, Michael S Anglesio, Raghwa Sharma, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 21, 2008
The Drosophila cohesin subunit Rad21 is a trithorax group (trxG) protein
Graham Hallson, Monika Syrzycka, Samantha A Beck, et al.
Genome Medicine
|
August 11, 2015
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
Georgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Genome Medicine
|
January 14, 2017
Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
Georgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 1, 2015
Copy number analysis of ductal carcinoma in situ with and without recurrence
Kylie L Gorringe, Sally M Hunter, Jia-Min Pang, et al.
Plos One
|
April 23, 2014
Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment
Jason Li, Maria A Doyle, Isaam Saeed, et al.
Oncotarget
|
October 28, 2015
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
Sally M Hunter, Michael S Anglesio, Georgina L Ryland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver
Catherine Emmanuel, Yoke-Eng Chiew, Joshy George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
Adrian Minson, Emma Verner, Pratyush Giri, et al.
Gynecologic Oncology
|
January 7, 2020
Therapeutic options for mucinous ovarian carcinoma
Kylie L Gorringe, Dane Cheasley, Matthew J Wakefield, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Copy number aberrations in benign serous ovarian tumors: a case for reclassification?
Sally M Hunter, Michael S Anglesio, Raghwa Sharma, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 21, 2008
The Drosophila cohesin subunit Rad21 is a trithorax group (trxG) protein
Graham Hallson, Monika Syrzycka, Samantha A Beck, et al.
Genome Medicine
|
August 11, 2015
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
Georgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Genome Medicine
|
January 14, 2017
Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
Georgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 1, 2015
Copy number analysis of ductal carcinoma in situ with and without recurrence
Kylie L Gorringe, Sally M Hunter, Jia-Min Pang, et al.
Plos One
|
April 23, 2014
Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment
Jason Li, Maria A Doyle, Isaam Saeed, et al.
Oncotarget
|
October 28, 2015
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
Sally M Hunter, Michael S Anglesio, Georgina L Ryland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver
Catherine Emmanuel, Yoke-Eng Chiew, Joshy George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2025
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
Adrian Minson, Emma Verner, Pratyush Giri, et al.
Gynecologic Oncology
|
January 7, 2020
Therapeutic options for mucinous ovarian carcinoma
Kylie L Gorringe, Dane Cheasley, Matthew J Wakefield, et al.
Page
of 3